Exelixis Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update Post author:Sam Post published:February 27, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>Oscar</b> Winner Turned Pharma CEO: We???ll Prevent Genital Herpes March 7, 2017 Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy February 23, 2017 Cepheid Wins FDA Nod to Market Xpert Xpress Strep A October 4, 2017
Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy February 23, 2017